Literature DB >> 15240637

Defective liver disposal of free fatty acids in patients with impaired glucose tolerance.

Patricia Iozzo1, Anu K Turpeinen, Teemu Takala, Vesa Oikonen, Jörgen Bergman, Tove Grönroos, Ele Ferrannini, Pirjo Nuutila, Juhani Knuuti.   

Abstract

The liver exchanges high fluxes of glucose and free fatty acids (FFA) and is one main site of their reciprocal regulation. Acute exposure to hyperglycemia and hyperinsulinemia has been shown to reduce splanchnic beta-oxidation in healthy humans. We investigated whether a spontaneous condition of chronic mild hyperglycemia and hyperinsulinemia affects liver FFA uptake. Hepatic FFA influx rate constant (LKi) was measured after a 12-15-h fast in 10 patients with impaired glucose tolerance (IGT) and eight control subjects using positron emission tomography in combination with the long-chain FFA analog 14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid. Compared with controls, IGT patients had higher serum insulin, glucose, and triglyceride levels (1.71 +/- 0.24 vs. 0.59 +/- 0.06 mmol/liter, P < 0.001), lower high-density lipoprotein (1.04 +/- 0.11 vs. 1.42 +/- 0.13 mmol/liter, P < 0.05), and similar FFA levels (0.59 +/- 0.06 vs. 0.56 +/- 0.05 mmol/liter(-1), P = not significant). LKi was significantly reduced in IGT (0.288 +/- 0.014 min(-1)) compared with control subjects (0.341 +/- 0.014 min(-1), P < 0.02). LKi was negatively correlated with plasma glucose (r = 0.51, P < 0.03), glycosylated hemoglobin (r = 0.55, P < 0.02), and blood lactate levels (r = 0.52, P < 0.03). We conclude that, in IGT patients, the ability of the liver to extract FFA from the circulation appears to be impaired. The reciprocal relationship between hepatic FFA extraction and glucose/lactate flux may derive from intrahepatic substrate competition.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15240637     DOI: 10.1210/jc.2003-031142

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  12 in total

1.  Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease.

Authors:  Jennifer E Lambert; Maria A Ramos-Roman; Jeffrey D Browning; Elizabeth J Parks
Journal:  Gastroenterology       Date:  2013-12-04       Impact factor: 22.682

2.  Hypolipidemic activity of Semecarpus anacardium in Streptozotocin induced diabetic rats.

Authors:  Aseervatham Jaya; Palanivelu Shanthi; Panchanatham Sachdanandam
Journal:  Endocrine       Date:  2010-06-24       Impact factor: 3.633

3.  Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism.

Authors:  Michihiro Matsumoto; Seongah Han; Tadahiro Kitamura; Domenico Accili
Journal:  J Clin Invest       Date:  2006-08-10       Impact factor: 14.808

Review 4.  NAFLD and diabetes mellitus.

Authors:  Herbert Tilg; Alexander R Moschen; Michael Roden
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-10-12       Impact factor: 46.802

Review 5.  Bringing physiology into PET of the liver.

Authors:  Susanne Keiding
Journal:  J Nucl Med       Date:  2012-02-09       Impact factor: 10.057

Review 6.  Quantitative PET of liver functions.

Authors:  Susanne Keiding; Michael Sørensen; Kim Frisch; Lars C Gormsen; Ole Lajord Munk
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-04-25

7.  Glucose dysregulation and hepatic steatosis in obese adolescents: is there a link?

Authors:  Anna M G Cali; Ana Mayra De Oliveira; Hyeonjin Kim; Shu Chen; Miguel Reyes-Mugica; Sandra Escalera; James Dziura; Sara E Taksali; Romy Kursawe; Melissa Shaw; Mary Savoye; Bridget Pierpont; R Todd Constable; Sonia Caprio
Journal:  Hepatology       Date:  2009-06       Impact factor: 17.425

8.  Liver fat content in type 2 diabetes: relationship with hepatic perfusion and substrate metabolism.

Authors:  Luuk J Rijzewijk; Rutger W van der Meer; Mark Lubberink; Hildo J Lamb; Johannes A Romijn; Albert de Roos; Jos W Twisk; Robert J Heine; Adriaan A Lammertsma; Johannes W A Smit; Michaela Diamant
Journal:  Diabetes       Date:  2010-08-06       Impact factor: 9.461

9.  Seeing is believing: dietary fatty acids hurry up from the stomach to the heart of patients with impaired glucose tolerance.

Authors:  Patricia Iozzo
Journal:  Diabetes       Date:  2012-11       Impact factor: 9.461

Review 10.  Membrane flexibility, free fatty acids, and the onset of vascular and neurological lesions in type 2 diabetes.

Authors:  Rob N M Weijers
Journal:  J Diabetes Metab Disord       Date:  2016-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.